Clinical Trial Update: Lenalidomide in Relapsed or Refractory Primary-cutaneous Large B-cell Lymphoma Leg-type : Multicentre Prospective Phase II Single Arm Trial of the French Study Group of Cutaneous Lymphoma [Phase 2]

View source ↗

Summary

Phase II multicenter single-arm trial evaluating lenalidomide in relapsed or refractory primary cutaneous large B-cell lymphoma, leg-type; the study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Large B-cell Lymphoma Leg-type

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Refractory Primary-cutaneous Large B-cell Lymphoma (Leg-type) | Phase 2 | Status: COMPLETED